Up to 1,600 people are set to benefit from a new treatment for aggressive breast cancer following new guidance from the National Institute for Health and Care Excellence (NICE) and a deal between NHS England and the manufacturer. Draft NICE guidance published today recommends pembrolizumab,…
The post NHS England to roll out ‘potentially life-saving’ breast cancer drug appeared first on Nursing Times.
0 comments:
Post a Comment